PepMLM generates binders to challenging therapeutic targets across cancer and neurological disease using protein sequence and ...

Researchers say work lays the foundation for a first-line, deployable antiviral platform that is virus agnostic and modular.

Antimicrobial resistance studies often focus on individual protein variants, neglecting broader protein family dynamics. Dihydrofolate reductase (DHFR), a key antibiotic target, has been extensively ...

Absci and Almirall have expanded their 21-month-old AI-based collaboration to develop and commercialize therapeutics for chronic skin diseases.

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

The basal ganglia in rats uses separate codes for learned movements and “natural” behaviors, offering insights into human ...

Model serves as platform for understanding how chronic inflammation related to alcohol consumption accelerates pancreatic cancer development.

AIs are as much a tool as a hammer or shovel, but to find the opportunities, we need to understand what the realities and risks are.

Sarepta Therapeutics said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene ...

An oxygen-generating implant keeps high-density insulin-producing cells alive in diabetic rats for months without immune suppression.

Researchers say the new concept that lithium deficiency could be a cause of Alzheimer’s disease points to a different ...

Knocking down EPIC1 sensitized triple negative breast tumor-bearing mice to immunotherapy with the PD-1 inhibitor pembrolizumab.